A method of inhibiting cancer in a subject in need thereof, said method comprising administering to the subject a therapeutically effective amount of at least one Myo/Nog cell targeting molecule and, optionally, at least one cytotoxic molecule.A method of detecting an increase risk for cancer or metastatic potential in a subject, said method comprising detecting Myo/Nog cells in a biological sample obtained from a subject, wherein an increase in Myo/Nog cells in the biological sample compared to a corresponding biological sample in a normal subject is indicative of an increased risk of cancer or metastatic potential in said subject.
